Abrahamsson Christina, Dota Corina, Skallefell Bo, Carlsson Leif, Frison Lars, Berggren Anders, Edvardsson Nils, Duker Göran
AstraZeneca R&D, Mölndal, Sweden.
Ann Noninvasive Electrocardiol. 2013 May;18(3):240-50. doi: 10.1111/anec.12016. Epub 2012 Nov 22.
We analyzed ventricular repolarization variability in genotyped long QT syndrome (LQTS) patients and in healthy volunteers (HV).
The deltaT50, that is, the temporal variability of ventricular repolarization at 50% of the T-wave downslope, was analyzed every 15th minute on 175 and 390 Holter electrocardiogram (ECG) recordings from HV and genotyped LQTS patients, respectively. The average deltaT50 and QTcF were calculated in each subject.
DeltaT50 was 2.26 ± 0.71 ms (mean ± SD) in the HV and 5.74 ± 2.30 ms in the LQTS population (P < 0.0001). The sensitivity and specificity of QTcF (cutoff value 450 ms) to discriminate between the LQTS patients and the HV were 51.5% and 98.9%, and for deltaT50 (cutoff value 3 ms) 93.9% and 88.6%, respectively. The combination of both variables improved the diagnosis of the LQTS patients even further. Subgroups of LQTS patients at higher risk of cardiac events (with LQTS3, JLN, QTc > 500 ms or symptoms) had higher deltaT50 than subgroups at lower risk (with LQTS1, QTc < 450 ms or without symptoms). The variation in deltaT50 between day and night was concordant with the risk of symptoms; patients with LQTS1 had higher deltaT50 in the daytime and patients with LQTS3 had higher deltaT50 during the night.
DeltaT50 more accurately distinguished between LQTS patients and HV than QTcF and was higher in LQTS patients with a higher risk of cardiac events. DeltaT50 can be used together with QTcF to improve the diagnosis in patients with the LQTS phenotype and tentatively also be of value for risk assessment in such patients.
我们分析了基因分型的长QT综合征(LQTS)患者和健康志愿者(HV)的心室复极变异性。
分别对175例HV和基因分型的LQTS患者的动态心电图(ECG)记录每15分钟分析一次deltaT50,即T波下降支50%处心室复极的时间变异性。计算每个受试者的平均deltaT50和QTcF。
HV组的deltaT50为2.26±0.71毫秒(均值±标准差),LQTS组为5.74±2.30毫秒(P<0.0001)。QTcF(临界值450毫秒)区分LQTS患者和HV的敏感性和特异性分别为51.5%和98.9%,而deltaT50(临界值3毫秒)的敏感性和特异性分别为93.9%和88.6%。两个变量的联合使用进一步改善了LQTS患者的诊断。心脏事件风险较高的LQTS患者亚组(LQTS3、JLN、QTc>500毫秒或有症状)的deltaT50高于风险较低的亚组(LQTS1、QTc<450毫秒或无症状)。deltaT50在白天和夜间的变化与症状风险一致;LQTS1患者白天的deltaT50较高,LQTS3患者夜间的deltaT50较高。
与QTcF相比,deltaT50能更准确地区分LQTS患者和HV,且在心脏事件风险较高的LQTS患者中更高。DeltaT50可与QTcF一起用于改善LQTS表型患者的诊断,并且初步认为对这类患者的风险评估也有价值。